Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system

Journal of Neuroscience

Volumn 22, Issue 5, 2002, Pages 2005-2011

  Pommier, Blandine ^a   Beslot, Françoise ^a   Simon, Axelle ^a   Pophillat, Matthieu ^a   Matsui, Toshimitsu ^b   Dauge, Valérie ^a   Roques, Bernard P ^a   Noble, Florence ^a  

^a Laboratoire de Pharmacochimie   (France)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenylyl cyclase; Behavior; Binding; Cholecystokinin; Mutant mice; Opioid

Indexed keywords

ADENYLATE CYCLASE; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; DIZOCILPINE; ENKEPHALIN; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE PEPTIDE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; ENZYME INHIBITOR; MEMBRANE PROTEIN; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; OPIATE RECEPTOR;

ANALGESIA; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; FEMALE; HYPERALGESIA; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NEGATIVE FEEDBACK; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; WITHDRAWAL SYNDROME; ANIMAL; BINDING COMPETITION; BRAIN LEVEL; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; FEEDBACK SYSTEM; GENETICS; METABOLISM; MORPHINE ADDICTION; MOTOR ACTIVITY; MOUSE MUTANT; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; UPREGULATION;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; ANIMALS; BINDING, COMPETITIVE; BRAIN CHEMISTRY; ENZYME ACTIVATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FEEDBACK, BIOCHEMICAL; FEMALE; HYPERALGESIA; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID PEPTIDES; PAIN MEASUREMENT; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, OPIOID; SUBSTANCE WITHDRAWAL SYNDROME; UP-REGULATION;

EID: 0036489446     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-05-02005.2002     Document Type: Article

References (46)

1. Albert PR, Neve KA, Bunzow JR, Civelli O (1990) Coupling of cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactine secretion. J Biol Chem 265:2098-2104.
2. Baamonde A, Daugé V, Ruiz-Gayo M, Fulga IG, Turcaud S, Fournié-Zaluski MC, Roques BP (1992) Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation. Eur J Pharmacol 216:157-166.
3. Brown BL, Albano JDM, Ekins RP, Sgherzi AM (1971) A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphate. Biochem J 121:561-562.
4. Calenco-Choukroun G, Daugé V, Gacel G, Féger J, Roques BP (1991) Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area. Psychopharmacology 103:493-502.
5. Célèrier E, Laulin JP, Corcuff JB, Le Moal M, Simonnet G (2001) Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process. J Neurosci 21:4074-4080.
6. Cerne R, Jiang M, Randic M (1992) Cyclic adenosine 3′5′-monophosphate potentiates excitatory amino acid and synaptic responses of rat spinal dorsal horn neurons. Brain Res 596:111-123.
7. Cesselin F (1995) Opioid and anti-opioid. Clin Pharmacol 9:409-433.
8. Childers S (1991) Opioid receptor-coupled second messenger systems. Life Sci 48:1991-2003.
9. Cox BM (1993) Opioid receptor-G protein interactions: Acute and chronic effects of opioids. In: Opioids I, Ch 8 (Herz A, ed), pp 145-188. Berlin: Springer.
10. Crawley JN (1991) Cholecystokinin-dopamine interactions. Trends Pharmacol Sci 12:232-236.
11. Crawley JN, Corwin RL (1994) Biological actions of cholecystokinin. Peptides 15:731-755.
12. Daugé V, Roques BP (1995) Reward versus anxiety: The opposite pharmacology of opioids and CCK. In: Cholecystokinin and Anxiety from Neuron to Behavior, Molecular Biology Intelligence Unit, Ch 8 (Bradwejn J, Vasar E, eds), pp 151-171. Berlin: Springer.
13. Daugé V, Mauborgne A, Cesselin F, Fournié-Zaluski MC, Roques BP (1996) The dual peptidase inhibitor RB 101 induces a long lasting increase in the extracellular level of Met-enkephalin in the nucleus accumbens of freely moving rats. J Neurochem 67:1301-1308.
14. Fan GH, Zhou TH, Zhang WB, Pei G (1998) Suppression of phospholipase C blocks Gi-mediated inhibition of adenylyl cyclase activity. Eur J Pharmacol 341:317-322.
15. Fournié-Zaluski MC, Coric P, Turcaud S, Lucas E, Noble F, Maldonado R, Roques BP (1992) Mixed-inhibitor-prodrug as a new approach towards systemically active inhibitors of enkephalin degrading enzymes. J Med Chem 35:2474-2481.
16. Gall C, Lauterborn J, Burks D, Seroogy K (1987) Co-localization of enkephalins and cholecystokinin in discrete areas of rat brain. Brain Res 403:403-408.
17. Hökfelt T, Skirboll LR, Rehfeld JH, Gostein M, Markey K, Dann O (1980) A subpopulation mesencephalic neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing. Neuroscience 5:2093-2124.
18. Kalivas PW, Taylor S, Miller JS (1985) Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization. J Pharmacol Exp Ther 235:537-543.
19. Larcher A, Laulin JP, Célèrier E, Le Moal M, Simonnet G (1998) Acute tolerance associated with a single opiate administration: Involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84:583-589.
20. Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS anatomical and functional implications. Trends Neurosci 18:22-29.
21. Manzanedo C, Aguilar MA, Minarro J (1999) The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice. Psychopharmacology 143:82-88.
22. Nagata A, Ito M, Iwata N, Kuno J, Takano H, Minowa O, Chihara K, Matsui T, Noda T (1996) G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci USA 93:11825-11830.
23. Nestler EJ, Aghajanian G (1997) Molecular and cellular basis of addiction. Science 278:58-63.
24. Nichols ML, Bian D, Ossipov MH, Malan Jr TP, Porreca F (1996) Antiallodynic effects of a CCK-B antagonist in rats with nerve ligation injury: Role of endogenous enkephalins. Neurosci Lett 215:161-164.
25. 2-opioid agonists in rat caudate putamen. J Neurochem 65:125-133.
26. Noble F, Derrien M, Roques BP (1993) Modulation of opioid analgesia by CCK at the supraspinal level: Evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain. Br J Pharmacol 109:1064-1070.
27. Noble F, Fournié-Zaluski MC, Roques BP (1994) Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradation. Neuropharmacology 33:135-140.
28. Noble F, Wank A, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP (1999) International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev 51:745-781.
29. Randic M, Cheng G, Kojic L (1995) Kappa-opioid receptor agonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord. J Neurosci 15:6809-6826.
30. Rehfeld JF, Hansen HF, Marley PD, Stengaard-Pedersen K (1985) Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins. Ann NY Acad Sci 448:11-23.
31. 3H]diprenorphine binding. Brain Res 571:306-312.
32. Sarne Y, Rubovitch V, Fields A, Gafni M (1998) Dissociation between the inhibitory and stimulatory effects of opioid peptides on cAMP formation in SK-N-SH neuroblastoma cells. Biochem Biophys Res Commun 246:128-131.
33. Skinner K, Basbaum AI, Fields HL (1997) Cholecystokinin and enkephalin in brain stem pain modulating circuits. NeuroReport 8:2995-2998.
34. Smadja C, Maldonado R, Turcaud S, Fournié-Zaluski MC, Roques BP (1995) Opposite role of CCK-A and CCK-B receptors in the modulation of endogenous enkephalins antidepressant-like effects. Psychopharmacology 128:400-408.
35. Stengaard-Pedersen K, Larsson LI (1981) Comparative immunocytochemical localization of putative opioid ligands in the central nervous system. Histochemistry 73:89-114.
36. Suh HH, Collins KA, Tseng LF (1992) Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive Met-enkephalin induced by intraventricular beta-endorphin in the rat. Neuropeptides 21:131-137.
37. Svingos AL, Clarke CL, Pickel VM (1999) Localization of the deltaopioid receptor and dopamine transporter in the nucleus accumbens shell: Implications for opiate and psychostimulant cross-sensitization. Synapse 34:1-10.
38. Vaccarino AL, Olson GA, Olson RD, Kastin AJ (1999) Endogenous opiates: 1998. Peptides 20:1527-1574.
39. Valverde O, Maldonado R, Fournié-Zaluski MC, Roques BP (1994) Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins. J Pharmacol Exp Ther 270:77-88.
40. Van der Kooy D, Weinreich P, Nagy JI (1986) Dopamine and opiate receptors: Localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways. Neuroscience 19:139-146.
41. Vanegas H, Schaible H (2001) Prostaglandins and cycloxygenases in the spinal cord. Prog Neurobiol 64:327-363.
42. Wank SA (1995) Cholecystokinin receptors. Am J Physiol 269:G628-G646.
43. Wiesenfeld-Hallin Z, Xu XJ, Hugues J, Horwell DC, Hökfelt T (1990) PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc Natl Acad Sci USA 87:7105-7109.
44. Wiesenfeld-Hallin Z, de Arauja Lucas G, Alster P, Xu XJ, Hökfelt T (1999) Cholecystokinin/opioid interactions. Brain Res 848:78-89.
45. Willer JC, Le Bars D, de Broucker T (1990) Diffuse noxious inhibitory controls in man: Involvement of an opioidergic link. Eur J Pharmacol 182:347-356.
46. Zhang X, de Araujo Lucas G, Elde R, Wiesenfeld-Hallin Z, Hökfelt T (2000) Effect of morphine on cholecystokinin and mu-opioid receptor-like immunoreactivities in rat spinal dorsal horn neurons after peripheral axotomy and inflammation. Neuroscience 95:197-207.